More than 1,100 Participants Connect Online for MRAs and DKD Management Webinar Series
More than 1,100 participants from 107 countries joined the ISN webinar series on mineralocorticoid receptor antagonists (MRAs) and diabetic kidney disease (DKD) management held in October.
The use of MRAs in DKD has historically been limited by its adverse side effects. This webinar series highlighted new developments in a rapidly evolving field, presenting the outcomes of the FIDELIO and FIGARO trials and examining how these trial results might impact future clinical practice.
The ISN Education Working Group and the ISN Research Working Group put together an excellent program presenting engaging speakers, moderators, and interactive sessions to an international audience. The series was broadcast in English with Spanish and Japanese subtitles.
“Impressive numbers and great educational material delivered to the community. Loved the collaboration between the research and education WGs – certainly made a difference.“ Roberto Pecoits-Filho, ISN Education Working Group Chair and moderator of the webinar on MRAs in the future of DKD management.
Did you miss the live sessions? The recordings are available open-access on the ISN Academy:
- MRAs in CKD: Lessons from a scientist, and investigator and trialist (with subtitles in Spanish)
- MRAs in CKD: Amplification of the presentation of the main results of the FIGARO trial (with subtitles in Spanish and Japanese)
- (with subtitles in Spanish and Japanese)
This webinar series was supported with an unrestricted educational grant from 
